Nikhil Lalwani - Mar 7, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani
Stock symbol
ANIP
Transactions as of
Mar 7, 2023
Transactions value $
-$604,270
Form type
4
Date filed
3/9/2023, 05:44 PM
Previous filing
Apr 4, 2023
Next filing
Mar 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Tax liability -$416K -9.4K -3.33% $44.23 273K Mar 7, 2023 Direct F1
transaction ANIP Common Stock Tax liability -$189K -4.27K -1.56% $44.23 268K Mar 7, 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 25,013 shares of restricted stock, the grant of which was previously reported.
F2 Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 8,338 shares of restricted stock, the grant of which was previously reported.